FDA OKs First Fully Interoperable Continuous Glucose Monitoring System
The U.S. FDA has permitted marketing of the Dexcom G6 integrated continuous glucose monitoring (iCGM) system for determining blood glucose levels in those ages 2 and older. This enables developers of future iCGM systems to bring their products to market in the least burdensome manner possible, FDA officials say.
Read More